DCM
LJPC

Driehaus Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Driehaus Capital Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-121,051
Closed -$3.6M – 690
2017
Q2 		$3.6M Sell
121,051
-33,095
-21% -$948K 0.13% 177
2017
Q1 		$4.6M Buy
+154,146
New +$3.94M 0.16% 148

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Driehaus Capital Management's LJPC Position: Q3 2017 in Review

Driehaus Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2017, closing a stake of 121,051 shares — an estimated $3.6M sold.

Driehaus Capital Management first reported a position in LJPC in Q1 2017 and held it in 2 quarters. The position peaked at $4.6M in Q1 2017. 95 funds tracked by Wall St. Rank hold LJPC as of Q3 2017.

  • Driehaus Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2017 after selling out during the quarter.
  • Driehaus Capital Management sold 121,051 La Jolla Pharmaceutical Company shares in Q3 2017, an estimated $3.6M.
  • Driehaus Capital Management first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 2 quarters.
  • Driehaus Capital Management's La Jolla Pharmaceutical Company position peaked at $4.6M in Q1 2017.
  • 95 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2017.

Based on Driehaus Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.